Yusuke Sakamaki

1.2k total citations
23 papers, 972 citations indexed

About

Yusuke Sakamaki is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yusuke Sakamaki has authored 23 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 8 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yusuke Sakamaki's work include Renal Diseases and Glomerulopathies (7 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Yusuke Sakamaki is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Yusuke Sakamaki collaborates with scholars based in Japan, United States and Australia. Yusuke Sakamaki's co-authors include Hiroshi Itoh, Shu Wakino, Kazuhiro Hasegawa, Hirobumi Tokuyama, Takeshi Kanda, Hiroyuki Sasamura, Kôichi Hayashi, Hitoshi Minakuchi, Kaori Hayashi and Eiji Kubota and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Scientific Reports.

In The Last Decade

Yusuke Sakamaki

22 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuke Sakamaki Japan 14 409 312 180 171 139 23 972
Mei Tran United States 12 589 1.4× 425 1.4× 78 0.4× 216 1.3× 174 1.3× 13 1.2k
Jijia Hu China 18 397 1.0× 294 0.9× 59 0.3× 123 0.7× 61 0.4× 35 808
Tangli Xiao China 15 378 0.9× 534 1.7× 53 0.3× 119 0.7× 131 0.9× 29 1.1k
Iryna Voloshyna United States 16 349 0.9× 134 0.4× 60 0.3× 134 0.8× 123 0.9× 34 1.1k
Jun Feng China 18 363 0.9× 243 0.8× 58 0.3× 108 0.6× 71 0.5× 24 716
Can Wu China 13 333 0.8× 172 0.6× 62 0.3× 121 0.7× 65 0.5× 15 710
Tomoya Umezono Japan 17 213 0.5× 239 0.8× 54 0.3× 72 0.4× 90 0.6× 34 681
Yi Guan China 11 200 0.5× 134 0.4× 163 0.9× 111 0.6× 91 0.7× 20 622
Xiaofen Xiong China 16 592 1.4× 285 0.9× 28 0.2× 232 1.4× 147 1.1× 22 1.2k
Xinli Xu China 9 246 0.6× 322 1.0× 47 0.3× 54 0.3× 87 0.6× 12 690

Countries citing papers authored by Yusuke Sakamaki

Since Specialization
Citations

This map shows the geographic impact of Yusuke Sakamaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Sakamaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Sakamaki more than expected).

Fields of papers citing papers by Yusuke Sakamaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Sakamaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Sakamaki. The network helps show where Yusuke Sakamaki may publish in the future.

Co-authorship network of co-authors of Yusuke Sakamaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Sakamaki. A scholar is included among the top collaborators of Yusuke Sakamaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Sakamaki. Yusuke Sakamaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasegawa, Kazuhiro, Masanori Tamaki, Yusuke Sakamaki, & Shu Wakino. (2024). Nmnat1 Deficiency Causes Mitoribosome Excess in Diabetic Nephropathy Mediated by Transcriptional Repressor HIC1. International Journal of Molecular Sciences. 25(12). 6384–6384. 2 indexed citations
2.
Hasegawa, Kazuhiro, Yusuke Sakamaki, Masanori Tamaki, & Shu Wakino. (2022). Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2. Scientific Reports. 12(1). 13712–13712. 13 indexed citations
3.
Inoue, Rintaro, Yusuke Sakamaki, Takumi Takata, et al.. (2021). Elucidation of the mechanism of subunit exchange in αB crystallin oligomers. Scientific Reports. 11(1). 2555–2555. 10 indexed citations
4.
Hasegawa, Kazuhiro, Yusuke Sakamaki, Takahisa Kawaguchi, et al.. (2021). Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy. Journal of the American Society of Nephrology. 32(6). 1355–1370. 72 indexed citations
5.
Hishikawa, Akihito, Kaori Hayashi, Takaya Abe, et al.. (2019). Decreased KAT5 Expression Impairs DNA Repair and Induces Altered DNA Methylation in Kidney Podocytes. Cell Reports. 26(5). 1318–1332.e4. 30 indexed citations
6.
Hasegawa, Kazuhiro, Yusuke Sakamaki, Hitoshi Minakuchi, et al.. (2019). Role of Nampt-Sirt6 Axis in Renal Proximal Tubules in Extracellular Matrix Deposition in Diabetic Nephropathy. Cell Reports. 27(1). 199–212.e5. 74 indexed citations
7.
Hayashi, Kôichi, Toshihiko Suzuki, Yusuke Sakamaki, & Shinsuke Ito. (2018). Cardiac hypertrophy in chronic kidney disease—role of Aldosterone and FGF23. Renal Replacement Therapy. 4(1). 4 indexed citations
8.
Hasegawa, Kazuhiro, Shu Wakino, Yusuke Sakamaki, et al.. (2016). Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism. Current Hypertension Reviews. 12(2). 95–104. 21 indexed citations
9.
Hayashi, Kaori, Hiroyuki Sasamura, Mari Nakamura, et al.. (2015). Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria. Kidney International. 88(4). 745–753. 47 indexed citations
10.
Hayashi, Kaori, Hiroyuki Sasamura, Mari Nakamura, et al.. (2014). KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria. Journal of Clinical Investigation. 124(6). 2523–2537. 99 indexed citations
11.
Sakamaki, Yusuke, Konosuke Konishi, Kôichi Hayashi, et al.. (2013). Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation. BMC Nephrology. 14(1). 260–260. 16 indexed citations
12.
Hasegawa, Kazuhiro, Shu Wakino, Petra Šimić, et al.. (2013). Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nature Medicine. 19(11). 1496–1504. 387 indexed citations
13.
Sakamaki, Yusuke, Matsuhiko Hayashi, Shu Wakino, et al.. (2011). A Case of Membranous Nephropathy with Primary Biliary Cirrhosis and Cyclosporine-induced Remission. Internal Medicine. 50(3). 233–238. 6 indexed citations
14.
Hayashi, Kaori, Hiroyuki Sasamura, Kimiko Ishiguro, et al.. (2010). Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney International. 78(1). 69–78. 35 indexed citations
15.
Sakamaki, Yusuke, Hiroyuki Sasamura, Kaori Hayashi, et al.. (2010). Absence of Gelatinase (MMP-9) or Collagenase (MMP-13) Attenuates Adriamycin-Induced Albuminuria and Glomerulosclerosis. Nephron Experimental Nephrology. 115(2). e22–e32. 19 indexed citations
16.
Ishiguro, Kimiko, Kaori Hayashi, Hiroyuki Sasamura, Yusuke Sakamaki, & Hiroshi Itoh. (2008). “Pulse” Treatment With High-Dose Angiotensin Blocker Reverses Renal Arteriolar Hypertrophy and Regresses Hypertension. Hypertension. 53(1). 83–89. 23 indexed citations
17.
Ishiguro, Kimiko, Hiroyuki Sasamura, Yusuke Sakamaki, et al.. (2008). Differential Effects of Transient Treatment of Spontaneously Hypertensive Rats with Various Antihypertensive Agents on the Subsequent Development of Diabetic Nephropathy. Nephron Experimental Nephrology. 109(1). e20–e28. 7 indexed citations
18.
Ishiguro, Kimiko, Hiroyuki Sasamura, Yusuke Sakamaki, Hiroshi Itoh, & Takao Saruta. (2007). Developmental Activity of the Renin-Angiotensin System during the "Critical Period" Modulates Later L-NAME-Induced Hypertension and Renal Injury. Hypertension Research. 30(1). 63–75. 35 indexed citations
19.
Sakamaki, Yusuke, Hiroyuki Sasamura, Shunya Ikeda, Naoki Ikegami, & Takao Saruta. (2006). Comparison of Health Costs Associated with Treatment of Hypertension with a Calcium Channel Blocker and Angiotensin-Converting Enzyme Inhibitor in the United States and Japan. Hypertension Research. 29(5). 333–338. 7 indexed citations
20.
Takenaka, Tsuneo, Hiromichi Suzuki, Hideki Ikenaga, et al.. (1994). Effects of a Calcium Channel Blocker, Nicardipine, on Pressure-Natriuresis in Dahl Salt-Sensitive Rats. Clinical and Experimental Hypertension. 16(1). 77–88. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei Tran Breakdown of academic impact, for papers by Jijia Hu Breakdown of academic impact, for papers by Tangli Xiao Breakdown of academic impact, for papers by Iryna Voloshyna Breakdown of academic impact, for papers by Jun Feng Breakdown of academic impact, for papers by Can Wu Breakdown of academic impact, for papers by Tomoya Umezono Breakdown of academic impact, for papers by Yi Guan Breakdown of academic impact, for papers by Xiaofen Xiong Breakdown of academic impact, for papers by Xinli Xu
Rankless by CCL
2026